A detailed history of Wellington Shields Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wellington Shields Capital Management, LLC holds 3,210 shares of NVO stock, worth $280,457. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,210
Previous 3,150 1.9%
Holding current value
$280,457
Previous $449,000 14.92%
% of portfolio
0.07%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $7,144 - $8,725
60 Added 1.9%
3,210 $382,000
Q2 2024

Aug 05, 2024

BUY
$122.71 - $146.91 $28,223 - $33,789
230 Added 7.88%
3,150 $449,000
Q4 2023

Feb 09, 2024

SELL
$87.78 - $105.45 $43,890 - $52,725
-500 Reduced 14.62%
2,920 $302,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $311,014 - $682,426
3,420 New
3,420 $311,000
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $105,872 - $127,311
800 New
800 $127,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wellington Shields Capital Management, LLC Portfolio

Follow Wellington Shields Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.